EverHint – Dip Bounce V2 (Reclaim) – Top 15 Signals for Jun 08, 2026
Excerpt: 15 signals (from 36 total). Healthcare leads (15). price range $20-$407. 8 with insider selling.
What This Signal Is
Production-ready dip-bounce strategy using reclaim pattern with Phase 2 market regime filters. Improved win rate from 40.42% (V1) to 50.18% (V2) with VIX and record high filters.
Entry Criteria:
- Minimum dip: 3.3% (open to intraday low)
- Minimum bounce: 1.0% from low
- Net change range: -2.0% to +0.3%
- Price above SMA(200)
- Minimum ADV: $40M
Holding period: 1-5 days | Risk level: Medium
Market Context
The sharp 13% decline in the VIX to 18.69 signals a meaningful easing of near-term fear, creating a more favorable backdrop for dip-bounce strategies. Lower volatility typically compresses intraday price ranges, which can reduce the whipsaw risk that often undermines reclaim setups — but it also means confirmed reclaims carry more conviction when they do emerge. The current VIX level sits in a moderate zone, neither complacent nor elevated, suggesting the market is transitioning rather than trending cleanly in either direction.
The mixed index performance tells a nuanced story about risk appetite. Nasdaq's outperformance at +0.86% reflects continued rotation into growth and technology-adjacent names, while the Dow's slight decline hints at softness in more defensive, value-oriented sectors. This divergence supports a selective approach to dip-bounce signals — momentum is rewarding higher-beta, growth-sensitive setups more than broad market participation would suggest.
Healthcare leading as the top sector among today's 36 signals is noteworthy from a rotation standpoint. Healthcare often attracts capital during periods of uncertainty or when investors seek relative stability without fully retreating to cash. With volatility cooling and growth sectors outperforming, Healthcare's prominence may reflect early defensive positioning or a sector-specific technical setup rather than broad risk-off sentiment. Traders should weigh whether individual signals are riding genuine sector strength or simply benefiting from the day's volatility compression.
📊 Signals (15 of 36 total)
Ranked by dip magnitude (highest first)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | INCY | Incyte Corporation | Healthcare | $100.64 | 0.32 | — | $20.1B |
| 2 | PSA | Public Storage | Real Estate | $311.08 | 0.29 | — | $54.6B |
| 3 | NSA | National Storage Affil... | Real Estate | $43.62 | 0.29 | — | $3.4B |
| 4 | BELFB | Bel Fuse Inc. | Technology | $279.13 | 0.28 | — | $3.4B |
| 5 | CUBE | CubeSmart | Real Estate | $40.17 | 0.28 | — | $9.1B |
| 6 | TNGX | Tango Therapeutics, Inc. | Healthcare | $30.93 | 0.28 | — | $3.6B |
| 7 | UTF | Cohen & Steers Infrast... | Financial Services | $27.09 | 0.27 | — | $2.6B |
| 8 | BELFA | Bel Fuse Inc. | Technology | $247.26 | 0.26 | — | $3.1B |
| 9 | NVRI | Enviri Corporation | Industrials | $19.88 | 0.25 | -$3,623,275 | $1.6B |
| 10 | CENTA | Central Garden & Pet C... | Consumer Defensive | $35.24 | 0.25 | — | $2.2B |
| 11 | AAOI | Applied Optoelectronic... | Technology | $196.64 | 0.22 | — | $15.8B |
| 12 | OSCR | Oscar Health, Inc. | Healthcare | $27.39 | 0.20 | — | $7.1B |
| 13 | UNH | UnitedHealth Group Inc... | Healthcare | $406.57 | 0.20 | — | $369.2B |
| 14 | CVS | CVS Health Corporation | Healthcare | $97.08 | 0.18 | — | $123.9B |
| 15 | AMGN | Amgen Inc. | Healthcare | $345.73 | 0.17 | -$1,180,076 | $186.6B |
Field Notes
Sector concentration: Healthcare (15), Financial Services (6), Industrials (6)
Insider selling: NVRI (Enviri Corporation, -$3,623,275), AMGN (Amgen Inc., -$1,180,076)
Data coverage: 22.2% insider, 8.3% congressional, 0.0% earnings, 11.1% news
Peer Analysis
TNGX (Tango Therapeutics, Inc.): Leads 5 peers: SEPN ($30.41), URGN ($27.25), PROK ($1.71), EYPT ($11.45), BCAX ($20.10)
NVRI (Enviri Corporation): Leads 5 peers: BLDP ($5.16), GSL ($37.84), RDW ($18.57), PRSU ($44.60), SFL ($11.00)
CUBE (CubeSmart): Leads 5 peers: REXR ($33.96), FRT ($122.10), EGP ($197.41), FR ($60.89), BRX ($30.93)
Congressional Activity
UNH (UnitedHealth Group Incorporated) 🔴 Bearish
- 2 sales by 2 members
PH (Parker-Hannifin Corporation) 🔴 Bearish
- 1 sale by 1 member
CVS (CVS Health Corporation) 🔴 Bearish
- 1 sale by 1 member
Recent Headlines
AAOI (Applied Optoelectronics, Inc.)
- Buy The Dip? Not So Fast.
AMGN (Amgen Inc.)
- Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
TNGX (Tango Therapeutics, Inc.)
- Tango Therapeutics, Inc. (TNGX) Discusses Promising Clinical Results for Vopimetostat and Pan-RAS Inhibitor Combination in MTAP-Deleted Pancreatic Cancer Transcript
- Tango Therapeutics Announces Proposed $500 Million Public Offering
- Tango Therapeutics stock soars on promising pancreatic cancer data
- Tango Therapeutics Stock Soars 42% After 'Unprecedented' Data on Pancreatic Cancer Treatment
- Tango Therapeutics, American Battery Technology, Intel And Other Big Stocks Moving Higher On Monday
- Tango Therapeutics' pancreatic cancer drug combo shows promise in study
UNH (UnitedHealth Group Incorporated)
- UnitedHealth Group (UNH) is a Top-Ranked Value Stock: Should You Buy?
- AbbVie, UnitedHealth, Sabra Health Care And A Consumer Defensive Stock On CNBC's 'Final Trades'
Vlad's Take
Today's signals: Strong sector concentration in Healthcare (15 signals) suggests sector-specific rotation. 8 signals showing insider selling warrant caution. 3 signals with congressional selling warrant attention.
Trading tips for this strategy:
- Entry timing: Consider entering on next-day weakness or at previous day's close level
- Position sizing: Start small (1-2% of portfolio per signal)
- Stop loss: Below today's low (tight stops for mean reversion)
- Take profit: 3-5% bounce target, or previous day's high
- Time stop: Exit if no bounce in 1-3 days
Risk warning: Mean reversion can fail in strong downtrends - check broader market context
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.